Skip to main content
. 1999 Mar;115(3):464–471. doi: 10.1046/j.1365-2249.1999.00828.x

Fig. 2.

Fig. 2

Survival estimations comparing IgG anti-phosphatidylserine antibody (APSA)+ (○) and IgG APSA (•) individuals. Individuals with severe immunodeficiency (CD4+ T lymphocytes < 0.2/nl) and positive APSA IgG tended to have a longer survival compared with subjects with severe immunodeficiency, but negative APSA IgG (P = 0.106, log-rank test).